Menu
Back to User profile » Dr Nicolas W Shammas
Papers published by Dr Nicolas W Shammas:
Jetstream Atherectomy with Paclitaxel-Coated Balloons: Two-Year Outcome of the Prospective Randomized JET-RANGER Study
Shammas NW, Shammas G, Christensen L, Jones-Miller S
Vascular Health and Risk Management 2023, 19:133-137
Published Date: 11 March 2023
A Regional Health System Journey from Volume to Value: Roadmap to the Recognition as a 15 Top Health System in the USA for Quality Excellence
Harb NH, Said PA, Gusta SL, Wesson AM, Brautigam JD, Lemke JH, DeLessio ST, Cropper DP, Shammas NW
Journal of Healthcare Leadership 2022, 14:203-213
Published Date: 5 December 2022
Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study
Shammas NW, Purushottam B, Shammas WJ, Christensen L, Shammas G, Weakley D, Jones-Miller S
Vascular Health and Risk Management 2022, 18:603-615
Published Date: 2 August 2022
How Much Debulking with Atherectomy is Enough When Treating Infrainguinal Arterial Interventions? The Balance Between Residual Stenosis and Adventitial Injury
Shammas NW
Vascular Health and Risk Management 2022, 18:211-218
Published Date: 5 April 2022
Sex-Related Differences in the Outcomes of Endovascular Interventions for Chronic Limb-Threatening Ischemia: Results from the LIBERTY 360 Study
Giannopoulos S, Shammas NW, Cawich I, Staniloae CS, Adams GL, Armstrong EJ
Vascular Health and Risk Management 2020, 16:271-284
Published Date: 8 July 2020
An Overview of the Treatment of Symptomatic Common Femoral Artery Lesions with a Focus on Endovascular Therapy
Shammas NW, Abi Doumet A, Karia R, Khalafallah R
Vascular Health and Risk Management 2020, 16:67-73
Published Date: 20 February 2020
The role of precise imaging with intravascular ultrasound in coronary and peripheral interventions
Shammas NW, Radaideh Q, Shammas WJ, Daher GE, Rachwan RJ, Radaideh Y
Vascular Health and Risk Management 2019, 15:283-290
Published Date: 7 August 2019
Iliac vein compression: epidemiology, diagnosis and treatment
Radaideh Q, Patel NM, Shammas NW
Vascular Health and Risk Management 2019, 15:115-122
Published Date: 9 May 2019
Ten-year outcome of intraoperative treatment of atrial fibrillation using radiofrequency ablation
Boulad N, Shammas NW, Early G, Roberts S, Shammas GA, Hu YL, Park H, Jerin M
Therapeutics and Clinical Risk Management 2017, 13:1233-1237
Published Date: 19 September 2017
Predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure
Shammas NW, Shammas GA, Jones-Miller S, Gumpert MR, Gumpert MJ, Harb C, Chammas MZ, Shammas WJ, Khalafallah RA, Barzgari A, Bou Dargham B, Daher GE, Rachwan RJ, Shammas AN
Therapeutics and Clinical Risk Management 2017, 13:401-406
Published Date: 30 March 2017
Ranolazine versus placebo in patients with ischemic cardiomyopathy and persistent chest pain or dyspnea despite optimal medical and revascularization therapy: randomized, double-blind crossover pilot study
Shammas NW, Shammas GA, Keyes K, Duske S, Kelly R, Jerin M
Therapeutics and Clinical Risk Management 2015, 11:469-474
Published Date: 23 March 2015
Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center
Shammas NW, Shammas GA, Jerin M, Sharis P
Vascular Health and Risk Management 2014, 10:563-568
Published Date: 9 September 2014
Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center
Shammas NW, Shammas GA , Nader E, Jerin M, Mrad L, Marogil P, Henn C, Dvorak A, Chintalapani A, Meriner S
Vascular Health and Risk Management 2012, 8:205-211
Published Date: 11 April 2012